Hasten Biopharmaceutic (China) has acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational healthcare company, Roche. Under the agreement, Hasten acquired Roche’s China mainland rights for
Tags :Lenz & Staehelin
NCAB Group, the global full-service supplier of printed circuit boards listed on Nasdaq Stockholm, has acquired the German db electronic, based in Waldshut-Tiengen in southern Germany, the db electronic in Switzerland and the db electronic
Partner One, one of the fastest growing enterprise software conglomerates, has announced that it had successfully acquired Stromasys, the world-leader in enterprise-class emulation solutions for legacy systems. Partner One’s acquisition marks a major milestone
Swiss Prime Site signed an agreement to sell its Wincasa group company, its real-estate services business, to Implenia for an enterprise value of CHF 235 million. Subject to regulatory approval, the transaction is expected to close
Sika has announced yesterday that it agreed to sell MBCC Group’s chemical admixtures assets in England, the USA, Canada, Europe, Australia, and New Zealand (Disposal Perimeter) to private equity firm Cinven. The divestment of
Relai, a Switzerland-based Bitcoin-only investment platform, announced the closing of a USD 4.5 million financing. The round was led by ego death capital (EDC), with further participation from Timechain, Cabrit Capital and Lightning Ventures, as well
Sika has placed bonds in a total amount of CHF 650 million, consisting of three tranches on 6 March 2023. The payment date of the new bonds is April 13, 2023 and the new bonds will be listed on SIX
Lenz & Staehelin partner Roman Graf has been elected President of the Commission for Continuing Legal Education (Commission de formation permanente) of the Geneva Bar Association. The bar association serves 1900 members in 450 law firms. For
SCCF Structured Commodity & Corporate Finance , the Swiss-based trade finance expert, has issued short term tokenized notes to refinance a loan to a commodity trading firm active in biofuels. The notes were tokenized using the
Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to develop and commercialize ASN90 in progressive supranuclear
